aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with gatifloxacin in 2 studies
Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (gatifloxacin) | Trials (gatifloxacin) | Recent Studies (post-2010) (gatifloxacin) |
---|---|---|---|---|---|
253 | 100 | 17 | 1,047 | 131 | 268 |
Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | gatifloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit A | Escherichia coli K-12 | 0.5 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.5 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 1.2 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 9.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koeppe, P; Lober, S; Lode, H; Mignot, A; Rau, M; Schreiber, G; Ziege, S | 1 |
Miyata, K; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
1 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and gatifloxacin
Article | Year |
---|---|
Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium.
Topics: Administration, Oral; Aluminum Hydroxide; Antacids; Anti-Infective Agents; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Fluoroquinolones; Gatifloxacin; Humans; Magnesium Hydroxide | 1999 |
1 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and gatifloxacin
Article | Year |
---|---|
Antacid interaction with new quinolones: dose regimen recommendations based on pharmacokinetic modeling of clinical data for ciprofloxacin, gatifloxacin and norfloxacin and metal cations.
Topics: Administration, Oral; Aluminum Hydroxide; Antacids; Anti-Infective Agents; Biological Availability; Cations; Ciprofloxacin; Drug Administration Schedule; Drug Combinations; Drug Interactions; Fluoroquinolones; Gatifloxacin; Humans; Intestinal Absorption; Magnesium Hydroxide; Models, Biological; Norfloxacin; Reference Values; Sucralfate | 2007 |